Giulia Colin

Dr. Giulia Colin


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
DDDaniela Dibello
Daniela Dibello
LTLucio Torelli
Lucio Torelli
VCVALENTINA DI CARLO
VALENTINA DI CARLO
ADAdamo Pio d'Adamo
Adamo Pio d'Adamo
Flavio FaletraFlavio Faletra
Flavio Faletra
GCGiulia Colin
Giulia Colin
(1) Background: We find the incidence of clubfoot in Italy from “Certificate of Delivery Care Registry (CeDAP)”, a database of the Italian Ministry of Health, the most comprehensive public data available for this purpose. (2) Methods: The CeDAP registry is a web system that provides epidemiological and sociodemographic information about newborns. It started on 1 January 2002, following the ministerial Decree no. 349 of 16 July 2001. The certificate is structured into six sections; each collects specific information referring to the birthplace, parents, pregnancy, childbirth, newborn, and the possible presence of congenital malformations or the causes of neonatal mortality. The midwife or the doctor draws up the certificate no later than ten days after birth. Each region transmits the data every six months to the Ministry of Health. The period between 2013 and 2017 has been selected for the study, with every Italian region’s data. We conducted a retrospective descriptive study. (3) Results: The overall rate in northern Italy is 1.09 (with some exceptions described), but we think it is essential to reevaluate this number again, given more accurate data collections by every Italian hospital. (4) Conclusions: This study intends to build a framework for future epidemiologic studies about clubfoot in Italy.

29 July 2022 in Children
Verified
Journal Article
Open access
PDF file
DDDaniela Dibello
Daniela Dibello
GCGiulia Colin
Giulia Colin
AGAnna Maria Chiara Galimberti
Anna Maria Chiara Galimberti
LTLucio Torelli
Lucio Torelli
VCVALENTINA DI CARLO
VALENTINA DI CARLO
(1) Background: The Ponseti Method is the gold standard for the treatment of congenital clubfoot. It is a low-cost treatment consisting in a series of plaster casts, a percutaneous Achilles’ tenotomy and a Mitchell Ponseti brace to wear with a definite protocol. This treatment allows children to be with their families instead of being hospitalized. This advantage is also a challenge for the families that have to follow the protocol at home. This paper aims to analyze the perception, the difficulties and the overcomes of the families during the treatment. (2) Methods: We used a 41 questions questionnaire by Nogueira and Morquende. Questions were answered by families who had already finished the treatment or were still following it. (3) Results: We interviewed 92 families. The worst handling phase appeared to be the cast phase, while the brace seemed more bearable. In total, 57 families overrated tenotomy; (4) Conclusions: Families perceived the Ponseti Method as a quality treatment. The anxiety about the diagnosis played a strong role, but none of the difficulties encountered decreased the treatment outcomes or affected families’ adherence to the protocol. The open-ended answers highlighted that the positive relationship with doctors played a key role in the everyday compliance and the achievement of good results.

Verified
Journal Article
Open access
PDF file
VCVALENTINA DI CARLO
VALENTINA DI CARLO
GCGiulia Colin
Giulia Colin
LTLucio Torelli
Lucio Torelli
MZMichela Zorzi
Michela Zorzi
ADAdamo Pio d'Adamo
Adamo Pio d'Adamo
DDDaniela Dibello
Daniela Dibello
Background: Clubfoot represents a prevalent congenital deformity of the foot and ankle complex that may significantly compromise a child’s walking ability. Contemporary treatment protocols encompass serial manipulations and casting procedures designed to achieve gradual correction of the deformity. Various casting materials have been employed in this therapeutic approach, with plaster of Paris and fiberglass constituting the two predominant options. This study aimed to evaluate the comparative effectiveness of these casting materials and determine whether material selection influences the rate of correction and the clinical indications, specifically regarding the number of casts required before percutaneous Achilles tenotomy. Methods: We conducted a retrospective analysis of prospectively collected data on paediatric patients treated at our tertiary-level institution with both plaster of Paris (POP) and semirigid fiberglass (SRF) by a single orthopaedic surgeon between 2010 and 2020. Treatment was initiated within the first 30 days of life (median age 12 days, range 0–28 days). To reduce confounding bias related to baseline aetiology (e.g., rigid syndromic feet), the primary comparative analysis was restricted to the idiopathic clubfoot subgroup. The Pirani score was used to assess deformity severity at each clinical visit. Results: A cohort of 84 patients (137 feet) was enrolled and treated, comprising patients with a Pirani score ≥ 4.5, excluding non-idiopathic cases. The mean number of casts required was 5.8 ± 1.0 for POP and 5.7 ± 1.2 for SRF, with no statistically significant difference (p = 0.91). Conclusions: Both plaster of Paris and semirigid fiberglass are highly effective casting materials for the initial phase of Ponseti treatment. Both achieve comparable correction sufficient to proceed with Achilles tenotomy. Accordingly, material selection should be guided by clinician proficiency, institutional cost-effectiveness, and patient comfort. Further investigation is needed to evaluate long-term outcomes and the relative benefits of each material in clubfoot management.